vs
Side-by-side financial comparison of Electromed, Inc. (ELMD) and FVCBankcorp, Inc. (FVCB). Click either name above to swap in a different company.
Electromed, Inc. is the larger business by last-quarter revenue ($18.9M vs $16.9M, roughly 1.1× FVCBankcorp, Inc.). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs 16.3%). FVCBankcorp, Inc. produced more free cash flow last quarter ($23.8M vs $2.4M). Over the past eight quarters, FVCBankcorp, Inc.'s revenue compounded faster (586.6% CAGR vs 16.7%).
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.
ELMD vs FVCB — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.9M | $16.9M |
| Net Profit | $2.8M | — |
| Gross Margin | 78.4% | — |
| Operating Margin | 19.2% | 43.7% |
| Net Margin | 14.6% | — |
| Revenue YoY | 16.3% | 4377.5% |
| Net Profit YoY | 40.3% | — |
| EPS (diluted) | $0.32 | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.9M | $16.9M | ||
| Q3 25 | $16.9M | $416.0K | ||
| Q2 25 | $17.4M | $15.8M | ||
| Q1 25 | $15.7M | $382.0K | ||
| Q4 24 | $16.3M | $378.0K | ||
| Q3 24 | $14.7M | $412.0K | ||
| Q2 24 | $14.8M | $415.0K | ||
| Q1 24 | $13.9M | $359.0K |
| Q4 25 | $2.8M | — | ||
| Q3 25 | $2.1M | $5.6M | ||
| Q2 25 | $2.2M | $5.7M | ||
| Q1 25 | $1.9M | $5.2M | ||
| Q4 24 | $2.0M | — | ||
| Q3 24 | $1.5M | $4.7M | ||
| Q2 24 | $1.8M | $4.2M | ||
| Q1 24 | $1.5M | $1.3M |
| Q4 25 | 78.4% | — | ||
| Q3 25 | 78.1% | — | ||
| Q2 25 | 78.3% | — | ||
| Q1 25 | 78.0% | — | ||
| Q4 24 | 77.7% | — | ||
| Q3 24 | 78.3% | — | ||
| Q2 24 | 76.2% | — | ||
| Q1 24 | 74.8% | — |
| Q4 25 | 19.2% | 43.7% | ||
| Q3 25 | 15.8% | — | ||
| Q2 25 | 17.5% | 45.9% | ||
| Q1 25 | 13.6% | — | ||
| Q4 24 | 15.6% | — | ||
| Q3 24 | 13.2% | — | ||
| Q2 24 | 15.7% | — | ||
| Q1 24 | 13.3% | — |
| Q4 25 | 14.6% | — | ||
| Q3 25 | 12.6% | 1341.1% | ||
| Q2 25 | 12.7% | 36.0% | ||
| Q1 25 | 12.1% | 1352.1% | ||
| Q4 24 | 12.1% | — | ||
| Q3 24 | 10.0% | 1133.3% | ||
| Q2 24 | 12.3% | 1001.2% | ||
| Q1 24 | 10.8% | 373.3% |
| Q4 25 | $0.32 | $0.31 | ||
| Q3 25 | $0.25 | $0.31 | ||
| Q2 25 | $0.26 | $0.31 | ||
| Q1 25 | $0.21 | $0.28 | ||
| Q4 24 | $0.22 | $0.27 | ||
| Q3 24 | $0.16 | $0.25 | ||
| Q2 24 | $0.20 | $0.23 | ||
| Q1 24 | $0.17 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $45.4M | $253.6M |
| Total Assets | $54.9M | $2.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.8M | — | ||
| Q3 25 | $14.1M | — | ||
| Q2 25 | $15.3M | — | ||
| Q1 25 | $15.2M | — | ||
| Q4 24 | $16.2M | — | ||
| Q3 24 | $13.9M | — | ||
| Q2 24 | $16.1M | — | ||
| Q1 24 | $11.7M | — |
| Q4 25 | $45.4M | $253.6M | ||
| Q3 25 | $44.7M | $249.8M | ||
| Q2 25 | $43.2M | $243.2M | ||
| Q1 25 | $43.9M | $242.3M | ||
| Q4 24 | $43.6M | $235.4M | ||
| Q3 24 | $41.5M | $230.8M | ||
| Q2 24 | $44.5M | $226.5M | ||
| Q1 24 | $42.5M | $220.7M |
| Q4 25 | $54.9M | $2.3B | ||
| Q3 25 | $53.6M | $2.3B | ||
| Q2 25 | $53.8M | $2.2B | ||
| Q1 25 | $52.5M | $2.2B | ||
| Q4 24 | $52.3M | $2.2B | ||
| Q3 24 | $48.9M | $2.3B | ||
| Q2 24 | $52.2M | $2.3B | ||
| Q1 24 | $48.9M | $2.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $23.9M |
| Free Cash FlowOCF − Capex | $2.4M | $23.8M |
| FCF MarginFCF / Revenue | 12.7% | 140.7% |
| Capex IntensityCapex / Revenue | 3.4% | 0.3% |
| Cash ConversionOCF / Net Profit | 1.10× | — |
| TTM Free Cash FlowTrailing 4 quarters | $7.9M | $40.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | $23.9M | ||
| Q3 25 | $169.0K | $7.6M | ||
| Q2 25 | $3.9M | $3.3M | ||
| Q1 25 | $2.1M | $5.4M | ||
| Q4 24 | $3.2M | $18.2M | ||
| Q3 24 | $2.3M | $4.7M | ||
| Q2 24 | $4.5M | $1.6M | ||
| Q1 24 | $1.4M | $7.2M |
| Q4 25 | $2.4M | $23.8M | ||
| Q3 25 | $-83.0K | $7.6M | ||
| Q2 25 | $3.7M | $3.3M | ||
| Q1 25 | $1.9M | $5.4M | ||
| Q4 24 | $2.9M | $18.1M | ||
| Q3 24 | $2.3M | $4.6M | ||
| Q2 24 | $4.5M | $1.5M | ||
| Q1 24 | $1.3M | $7.1M |
| Q4 25 | 12.7% | 140.7% | ||
| Q3 25 | -0.5% | 1818.0% | ||
| Q2 25 | 21.4% | 20.8% | ||
| Q1 25 | 12.2% | 1413.6% | ||
| Q4 24 | 18.0% | 4786.0% | ||
| Q3 24 | 15.5% | 1121.8% | ||
| Q2 24 | 30.1% | 361.2% | ||
| Q1 24 | 9.1% | 1988.3% |
| Q4 25 | 3.4% | 0.3% | ||
| Q3 25 | 1.5% | 0.2% | ||
| Q2 25 | 0.8% | 0.1% | ||
| Q1 25 | 1.0% | 4.2% | ||
| Q4 24 | 1.4% | 37.3% | ||
| Q3 24 | 0.3% | 14.1% | ||
| Q2 24 | 0.1% | 12.8% | ||
| Q1 24 | 0.6% | 3.9% |
| Q4 25 | 1.10× | — | ||
| Q3 25 | 0.08× | 1.36× | ||
| Q2 25 | 1.75× | 0.58× | ||
| Q1 25 | 1.10× | 1.05× | ||
| Q4 24 | 1.60× | — | ||
| Q3 24 | 1.57× | 1.00× | ||
| Q2 24 | 2.46× | 0.37× | ||
| Q1 24 | 0.90× | 5.34× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
FVCB
Segment breakdown not available.
